Annual Operating Expenses
$14.48 M
+$576.00 K+4.14%
31 December 2023
Summary:
Yield10 Bioscience annual total operating expenses is currently $14.48 million, with the most recent change of +$576.00 thousand (+4.14%) on 31 December 2023. During the last 3 years, it has risen by +$4.07 million (+39.09%). YTEN annual operating expenses is now -64.06% below its all-time high of $40.29 million, reached on 31 December 2011.YTEN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$3.65 M
+$913.00 K+33.32%
30 June 2024
Summary:
Yield10 Bioscience quarterly total operating expenses is currently $3.65 million, with the most recent change of +$913.00 thousand (+33.32%) on 30 June 2024. Over the past year, it has dropped by -$50.00 thousand (-1.35%). YTEN quarterly operating expenses is now -86.72% below its all-time high of $27.51 million, reached on 31 December 2010.YTEN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YTEN Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.1% | -1.4% |
| 3 y3 years | +39.1% | +14.8% |
| 5 y5 years | +46.6% | +64.4% |
YTEN Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +39.1% | -3.9% | +33.3% |
| 5 y | 5 years | at high | +54.0% | -3.9% | +64.4% |
| alltime | all time | -64.1% | +345.2% | -86.7% | +124.5% |
Yield10 Bioscience Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $3.65 M(+33.3%) |
| Mar 2024 | - | $2.74 M(-17.1%) |
| Dec 2023 | $14.48 M(+4.1%) | $3.31 M(-10.7%) |
| Sept 2023 | - | $3.70 M(+1.0%) |
| June 2023 | - | $3.67 M(-3.5%) |
| Mar 2023 | - | $3.80 M(+4.0%) |
| Dec 2022 | $13.90 M(+13.0%) | $3.65 M(+4.7%) |
| Sept 2022 | - | $3.49 M(-1.4%) |
| June 2022 | - | $3.54 M(+2.0%) |
| Mar 2022 | - | $3.47 M(+11.2%) |
| Dec 2021 | $12.31 M(+18.2%) | $3.12 M(-2.0%) |
| Sept 2021 | - | $3.18 M(-2.2%) |
| June 2021 | - | $3.25 M(+18.4%) |
| Mar 2021 | - | $2.75 M(-2.0%) |
| Dec 2020 | $10.41 M(+10.7%) | $2.81 M(+17.0%) |
| Sept 2020 | - | $2.40 M(+1.7%) |
| June 2020 | - | $2.36 M(-17.2%) |
| Mar 2020 | - | $2.85 M(+11.4%) |
| Dec 2019 | $9.40 M(-4.8%) | $2.56 M(+15.0%) |
| Sept 2019 | - | $2.22 M(+0.3%) |
| June 2019 | - | $2.22 M(-8.0%) |
| Mar 2019 | - | $2.41 M(+18.7%) |
| Dec 2018 | $9.88 M(-3.4%) | $2.03 M(-26.2%) |
| Sept 2018 | - | $2.75 M(+1.3%) |
| June 2018 | - | $2.72 M(+14.3%) |
| Mar 2018 | - | $2.38 M(-9.7%) |
| Dec 2017 | $10.23 M(-10.3%) | $2.63 M(+19.4%) |
| Sept 2017 | - | $2.21 M(-26.6%) |
| June 2017 | - | $3.00 M(+26.0%) |
| Mar 2017 | - | $2.38 M(+23.3%) |
| Dec 2016 | $11.41 M(-17.5%) | $1.93 M(-37.1%) |
| Sept 2016 | - | $3.08 M(+14.1%) |
| June 2016 | - | $2.70 M(-27.1%) |
| Mar 2016 | - | $3.70 M(+15.5%) |
| Dec 2015 | $13.82 M(-50.9%) | $3.20 M(-6.7%) |
| Sept 2015 | - | $3.43 M(-49.4%) |
| June 2015 | - | $6.78 M(+6.1%) |
| Mar 2015 | - | $6.39 M(-3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $28.15 M(-7.4%) | $6.60 M(+0.6%) |
| Sept 2014 | - | $6.56 M(-6.9%) |
| June 2014 | - | $7.04 M(-11.3%) |
| Mar 2014 | - | $7.94 M(+1.5%) |
| Dec 2013 | $30.41 M(-16.5%) | $7.83 M(+12.0%) |
| Sept 2013 | - | $6.99 M(-16.5%) |
| June 2013 | - | $8.37 M(+2.4%) |
| Mar 2013 | - | $8.17 M(-13.4%) |
| Dec 2012 | $36.42 M(-9.6%) | $9.43 M(+16.5%) |
| Sept 2012 | - | $8.10 M(-4.1%) |
| June 2012 | - | $8.44 M(-19.2%) |
| Mar 2012 | - | $10.44 M(+3.9%) |
| Dec 2011 | $40.29 M(+2.3%) | $10.06 M(+0.1%) |
| Sept 2011 | - | $10.05 M(-1.5%) |
| June 2011 | - | $10.20 M(+169.2%) |
| Mar 2011 | - | $3.79 M(-86.2%) |
| Dec 2010 | $39.39 M(+151.1%) | $27.51 M(+561.1%) |
| Sept 2010 | - | $4.16 M(+8.1%) |
| June 2010 | - | $3.85 M(-0.5%) |
| Mar 2010 | - | $3.87 M(-4.8%) |
| Dec 2009 | $15.68 M(-0.6%) | $4.06 M(+2.4%) |
| Sept 2009 | - | $3.97 M(+0.8%) |
| June 2009 | - | $3.94 M(+6.0%) |
| Mar 2009 | - | $3.71 M(-124.9%) |
| Dec 2008 | $15.78 M(-55.5%) | -$14.93 M(-240.6%) |
| Sept 2008 | - | $10.62 M(+5.6%) |
| June 2008 | - | $10.06 M(+0.2%) |
| Mar 2008 | - | $10.03 M(+5.5%) |
| Dec 2007 | $35.50 M(+60.5%) | $9.51 M(-4.6%) |
| Sept 2007 | - | $9.96 M(+6.2%) |
| June 2007 | - | $9.38 M(+40.9%) |
| Mar 2007 | - | $6.66 M(-24.0%) |
| Dec 2006 | $22.11 M(+478.0%) | $8.76 M(+79.7%) |
| Sept 2006 | - | $4.87 M(-1.5%) |
| June 2006 | - | $4.95 M(+39.8%) |
| Mar 2006 | - | $3.54 M |
| Dec 2005 | $3.83 M(+17.7%) | - |
| Dec 2004 | $3.25 M(-53.9%) | - |
| Dec 2002 | $7.05 M | - |
FAQ
- What is Yield10 Bioscience annual total operating expenses?
- What is the all time high annual operating expenses for Yield10 Bioscience?
- What is Yield10 Bioscience annual operating expenses year-on-year change?
- What is Yield10 Bioscience quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Yield10 Bioscience?
- What is Yield10 Bioscience quarterly operating expenses year-on-year change?
What is Yield10 Bioscience annual total operating expenses?
The current annual operating expenses of YTEN is $14.48 M
What is the all time high annual operating expenses for Yield10 Bioscience?
Yield10 Bioscience all-time high annual total operating expenses is $40.29 M
What is Yield10 Bioscience annual operating expenses year-on-year change?
Over the past year, YTEN annual total operating expenses has changed by +$576.00 K (+4.14%)
What is Yield10 Bioscience quarterly total operating expenses?
The current quarterly operating expenses of YTEN is $3.65 M
What is the all time high quarterly operating expenses for Yield10 Bioscience?
Yield10 Bioscience all-time high quarterly total operating expenses is $27.51 M
What is Yield10 Bioscience quarterly operating expenses year-on-year change?
Over the past year, YTEN quarterly total operating expenses has changed by -$50.00 K (-1.35%)